Suspected immunodeficiency in children
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First-line tests
Laboratory tests
- FBC (± blood film)
- Serum immunoglobulins (IgG, IgA, IgM)
- Vaccine serologies (DTP, Haemophilus, pneumococcus)
- blood group isohaemagglutininsif neededChild over 24 months: explores production of anti-polysaccharide antibodies.
- HIV serologyif neededTo rule out acquired immunodeficiency: the diagnosis of HIV infection should be considered at any age, even if the mother's serology was negative at the start of pregnancy.
- CH50, total haemolytic complement (if personal or family meningococcal meningitis, or invasive infection with an encapsulated bacterium)if neededPersonal or family history of meningococcal meningitis: the PNDS lists complement investigation among the possible tests reimbursed in the community; for invasive infection with an encapsulated bacterium, it places it in the second-line tests [2]. In the United States, an American Family Physician review measures complement in the initial tests for any suspected immunodeficiency in a child: a normal CH50 rules out a significant deficiency, and the alternative pathway (AH50) is measured only if it is abnormal (expert opinion, 2013) [3]. In Australia, ASCIA (2025) screens for complement deficiency with C3, C4, CH50 and AH50 for bacterial infection, especially Neisseria, autoimmunity or recurrent angio-oedema [4].
Do not order
- Serum protein electrophoresis: unhelpful in children for the diagnosis of hypogammaglobulinaemia, given the variations of IgG, IgA and IgM during childhood [2].
- IgG measurement before 3 to 4 months: reflects maternal IgG and cannot be interpreted [2].
- Multiplying vaccine serologies: tetanus, Haemophilus and pneumococcus are enough [2].
- Isolated IgG4 measurement: an isolated IgG4 deficiency is not an immunodeficiency [5].
If first-line tests are normal
Laboratory tests
- IgG subclass assay (IgG1, IgG2, IgG3, IgG4), after 18 to 24 months, in case of recurrent infections despite normal IgG
- Blood group isohaemagglutinins
- Blood film
- Complement work-up (CH50)
- Complement work-up (AP50)
- Total IgE
- T, B and NK lymphocyte phenotypingif neededSecond-line test of the PNDS in case of confirmed isolated lymphopenia, hypogammaglobulinaemia beyond 3 months, low or absent serology after a documented infection, or isolated defect of vaccine antibody production checked 4 to 6 weeks after a booster [2]; P. Frange proposes it if immunoglobulins, IgG subclasses or allohaemagglutinins are abnormal [5,6]. It is coded like the lymphocyte count by flow cytometry (CD3, CD4, CD8…), procedure 1122 [9]. The NABM names only the T lymphocyte subsets (procedure 1122): the coding of B and NK lymphocytes depends on the laboratory.
Sources (10)
- CEREDIH. Synthèse à destination du médecin traitant : PNDS Déficits immunitaires héréditaires. Avril 2023.
- Centre de référence constitutif des déficits immunitaires héréditaires (CEREDIH). PNDS Déficits immunitaires héréditaires de l'adulte et de l'enfant. Décembre 2022, mise en ligne HAS 2023 (non validé par la HAS).
- Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013;87(11):773-778.
- Australasian Society of Clinical Immunology and Allergy (ASCIA). Primary Immunodeficiencies (PID) Clinical Update. ASCIA Information for health professionals, 2025.
- Quand penser à un déficit immunitaire primitif de l’enfant ?
- Frange P. Quand penser à un déficit immunitaire primitif de l'enfant ? DES/DESC de maladies infectieuses, séminaire de mars 2025 (diaporama, CHU Necker-Enfants malades).
- de Vries E; European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167(1):108-19.
- UK National Screening Committee. Severe combined immunodeficiency (SCID) : recommandation sur le dépistage néonatal (dernière revue en novembre 2025).
- Caisse nationale de l’assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1122 et liste des actes actifs.
- ÉVOQUER ET DIAGNOSTIQUER UN DÉFICIT IMMUNITAIRE HÉRÉDITAIRE